Clomiphene for Fertility: Uses, Side Effects & Success Rates

Clomiphene (Clomid, Serophene) induces ovulation in women with irregular cycles and is often used with intrauterine insemination (IUI). It carries a 5% twin risk and may require up to three cycles before considering advanced treatments. Long-term use is limited due to potential ovarian cancer concerns.

---

Key Takeaways

Clomiphene for Ovulation Induction in Women with Infrequent Menstrual Cycles

Clomiphene is prescribed for women who do not ovulate regularly or have infrequent periods. Taken orally for 5-7 days, it stimulates follicular development and is most effective for primary ovulatory dysfunction.

Clomiphene and Intrauterine Insemination (IUI) for Unexplained Infertility Treatment

When combined with IUI, Clomiphene improves fertilization chances in cases of unexplained infertility or endometriosis by promoting the maturation of multiple eggs, typically resulting in 1-2 mature follicles per cycle.

Understanding Clomiphene’s 5% Twin Pregnancy Risk and Ovarian Hyperstimulation Syndrome (OHHS)

Clomiphene increases twin pregnancy odds to 5%. Rarely, it may cause OHHS—a condition marked by ovarian swelling and abdominal discomfort—especially in patients developing multiple follicles.

Evaluating Clomiphene Success Rates: When to Consider Advanced Fertility Treatments

Most patients achieve pregnancy within 3-6 months of Clomiphene use. If unsuccessful after three cycles, fertility specialists often transition to in vitro fertilization (IVF) or other interventions.

Clomiphene Use Limitations: Ovarian Cancer Concerns and Recommended Cycle Restrictions

To mitigate long-term ovarian cancer risks, Clomiphene is typically limited to 12 cycles. Pregnancy following treatment reduces cancer risk to baseline levels, emphasizing the importance of timely conception.

---

Source: Read full article